CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis)
Björkholm Magnus, Andersson Tomas, Ahlbom Anders, Ösby EvaVolume:
80
Year:
2008
Language:
english
Pages:
6
DOI:
10.1111/j.1600-0609.2008.01062.x
File:
PDF, 123 KB
english, 2008